Dr. Allan Tsung, MD
Vice Chair of Research, Department of Surgery
Professor and Raizman-Haney Chair in Surgery
Division of Hepatobiliary & Pancreatic Surgery
University of Pittsburgh School of Medicine
Co-Director, UPMC Liver Cancer Center
UPMC Montefiore, 7 South
3459 Fifth Avenue
Pittsburgh, PA 15213-2582
Phone: 412-692-2001 or Toll-free at 1-855-74-LIVER
Allan Tsung, MD, FACS, is Professor and Raizman-Haney Chair in the Department of Surgery, Division of Hepatobiliary & Pancreatic Surgery at the University of Pittsburgh School of Medicine. He serves as co-director of the UPMC Liver Cancer Center. His clinical interests center on the comprehensive care for all forms of liver, bile duct, and pancreas cancer. He is specialty-trained in liver and pancreatic surgery, with a focus on minimally invasive (laparoscopic and robotic) surgery. Dr. Tsung also co-leads the liver-directed therapy program utilizing hepatic artery chemoembolization and Yttrium 90 internal radiation for primary and metastatic liver cancers, bile duct cancers, and gallbladder carcinoma.
Dr. Tsung earned his medical degree at the SUNY Health Science Center at Brooklyn College of Medicine. He completed his general surgical residency and a fellowship in hepatobiliary and pancreas surgery at the University of Pittsburgh School of Medicine. His primary research interests are directed toward hepatobiliary and pancreas cancer clinical trials and the role of the tumor micro-environment in the progression of these cancers. Dr. Tsung has active research grants from the Howard Hughes Medical Institute and the NIH, and is also the Principal Investigator on multiple clinical trials for liver cancer. He is a member of the Society of Surgical Oncology and has authored more than 50 manuscripts and four book chapters.
- Tohme S, Goswami J, Han K, Chidi AP, Geller DA, Reddy S, Gleisner A, Tsung A. Minimally Invasive Resection of Colorectal Cancer Liver Metastases Leads to an Earlier Initiation of Chemotherapy Compared to Open Surgery. J Gastrointest Surg. 2015
- Geller DA, Tsung A. Long-term outcomes and safety of laparoscopic liver resection surgery for hepatocellular carcinoma and metastatic colorectal cancer. J Hepatobiliary Pancreat Sci. 2015; 22(10):728-30.
- Ocuin LM, Tsung A. Robotic liver resection for malignancy: Current status, oncologic outcomes, comparison to laparoscopy, and future applications. J Surg Oncol. 2015; 112(3):295-301.
- Shakir M, Boone BA, Polanco PM, Zenati MS, Hogg ME, Tsung A, Choudry HA, Moser AJ, Bartlett DL, Zeh HJ, Zureikat AH. The learning curve for robotic distal pancreatectomy: an analysis of outcomes of the first 100 consecutive cases at a high-volume pancreatic centre. HPB (Oxford). 2015; 17(7):580-6.
- Chidi AP, Bryce CL, Myaskovsky L, Fine MJ, Geller DA, Landsittel DP, Tsung A. Differences in Physician Referral Drive Disparities in Surgical Intervention for Hepatocellular Carcinoma: A Retrospective Cohort Study. Ann Surg. 2015.
- Tsung A, Geller DA, Sukato DC, Sabbaghian S, Tohme S, Steel J, Marsh W, Reddy SK, Bartlett DL.Robotic Versus Laparoscopic Hepatectomy: A Matched Comparison. Ann Surg. 2013; 259(3):549-55.
- Nguyen KT, Steel J, Vanounou T, Tsung A, Marsh JW, Geller DA, Clark
Gamblin T. Initial Presentation and Management of Hilar and Peripheral
Cholangiocarcinoma: Is a Node-Positive Status or Potential Margin-Positive
Result a Contraindication to Resection? Ann Surg Oncol. 2009; 16(12):3308-15.
- Vanounou T, Steel JL, Nguyen KT, Tsung A, Marsh JW, Geller DA, Gamblin TC.
Comparing the Clinical and Economic Impact of Laparoscopic Versus Open Liver Resection. Ann Surg Oncol. 2010; 17(4):998-1009.
- Geller DA, Tsung A, Marsh JW, Dvorchik I, Gamblin TC, Carr BI. Outcome of
1,000 Liver Cancer Patients Evaluated at the UPMC Liver Cancer Center. J
Gastrointest Surg. 2006; 10:63-68.